Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

July 27, 2017July 27, 2017

Scleroderma Patients May Develop Calcinosis, Study Says

News

Patients with scleroderma may develop calcinosis, a condition marked by abnormal deposits of calcium salts in the body’s soft tissues, a new study says. The study, “Are there risk ... Read more

June 22, 2017June 22, 2017

Rheumatologist Calls for More Screening of Scleroderma Patients for Pulmonary Hypertension

News

Many systemic sclerosis patients develop pulmonary arterial hypertension, but not all who are suspected of having PAH are referred for testing, according to rheumatologist Janet Pope. She called for ... Read more

June 20, 2017June 20, 2017

Phase 2 Trial Results Presented of Corbus’ Anabasum as Treatment for Systemic Sclerosis

News

Results of a Phase 2 clinical trial (NCT02465437) evaluating the effects of Corbus Pharmaceuticals’ anabasum (formerly known as Resunab or JBT-101) support this treatment as a potential option for ... Read more

May 16, 2017May 16, 2017

Systemic Sclerosis May Be Linked to Changes in Gut Bacteria, U.S.-Norwegian Study Finds

News

Systemic sclerosis (SSc) may be associated with changes in gut bacteria, according to a U.S.-Norwegian study which found that SSc patients are more prone to severe gastrointestinal tract (GIT) changes ... Read more

April 13, 2017April 13, 2017

Fibrocell Develops FCX-013 Investigational Gene Therapy for Treatment of Linear Scleroderma

News

Fibrocell Science of Exton, Pa., recently started a preclinical dose-ranging study for FCX-013, an investigational drug to treat linear scleroderma. The company expects to initiate a safety study and apply ... Read more

April 4, 2017April 4, 2017

Proteins KL-6 and SP-D Could Help Doctors Keep Tabs on Systemic Sclerosis-related Lung Disease

News

Blood levels of the KL-6 and SP-D proteins may help doctors monitor the progression of interstitial lung disease (ILD) associated with systemic sclerosis (SSc), a study reports. The research, ... Read more

February 23, 2017February 23, 2017

Foot Healthcare for Scleroderma Patients Inadequate, Needs Improvement, Study Says

News

People with systemic sclerosis (SSc) frequently experience foot problems, but foot assessment and healthcare for SSc patients are still inadequate, according to new research. The study, “Biomechanical Podiatric Evaluation ... Read more

February 21, 2017February 21, 2017

Researchers Link Severe Forms of Systemic Sclerosis with Fingernail Ailments

News

Patients with severe forms of systemic sclerosis (SSc) may frequently develop fingernail abnormalities, with such changes affecting four out of five SSc patients in a small study in France. The study, “Nail ... Read more

February 2, 2017February 2, 2017

Insecurity About Care, Isolation and Identity Loss Among SSc Patients’ Concerns, Study Finds

News

Systemic sclerosis (SSc) patients face significant bodily and social restrictions that undermine their self-image and confidence, and uncertainties about the disease’s cause and prognosis undercut their confidence in their care, ... Read more

January 19, 2017January 19, 2017

Resunab Granted Orphan Drug Status in EU as Potential Therapy for Systemic Sclerosis

News

The European Commission (EC) has designated Corbus Pharmaceuticals’ product Resunab (JBT-101) an Orphan Drug for the potential treatment of systemic sclerosis (SSc). Orphan Drug status is attributed to therapeutic drugs intended ... Read more